Comparison of the everolimus-eluting bioresorbable vascular scaffold versus the everolimus-eluting metallic stent in real-world patients with ST-segment elevation myocardial infarction

Comparison of the everolimus-eluting bioresorbable vascular scaffold versus the everolimus-eluting metallic stent in real-world patients with ST-segment elevation myocardial infarction

Bibliographic Details
Main Authors:	Piotr Desperak, Michał Hawranek, Piotr Chodór, Andrzej Świątkowski, Jacek Kowalczyk, Andrzej Lekston, Mariusz Gąsior
Format:	Article
Language:	English
Published:	Termedia Publishing House 2020-04-01
Series:	Advances in Interventional Cardiology
Subjects:	bioresorbable vascular scaffold primary percutaneous coronary intervention acute myocardial infarction/st-segment elevation myocardial infarction everolimus-eluting stent
Online Access:	https://www.termedia.pl/Comparison-of-the-everolimus-eluting-bioresorbable-vascular-scaffold-versus-the-everolimus-eluting-metallic-stent-in-real-world-patients-with-ST-segment-elevation-myocardial-infarction,35,40164,1,1.html

Similar Items

Safety and efficacy of biodegradable polymer-coated thin strut sirolimus-eluting stent vs. durable polymer-coated everolimus-eluting stent in patients with acute myocardial infarction
by: Paweł Gąsior, et al.
Published: (2018-11-01)

Everolimus-eluting stents versus sirolimus-eluting stents in patients with cardiac allograft vasculopathy
by: Michał Hawranek, et al.
Published: (2021-12-01)

Vascular response to everolimus- and biolimus-eluting coronary stents versus everolimus-eluting bioresorbable scaffolds – an optical coherence tomography substudy of the EVERBIO II trial
by: Zacharenia Kallinikou, et al.
Published: (2016-01-01)

Bioresorbable scaffolds vs. drug-eluting stents for patients with myocardial infarction: A systematic review and meta-analysis of randomized clinical trials
by: Yong Liu, et al.
Published: (2022-10-01)

Three-Year Clinical Outcomes With the Cilotax Dual Drug-Eluting Stent vs Everolimus-Eluting Stents in Patients With Acute Myocardial Infarction
by: HyeYon Yu, PhD, et al.
Published: (2024-05-01)

A meta-analysis of everolimus-eluting stents versus sirolimus-eluting stents and paclitaxel-eluting stents in diabetic patients
by: Hang Ouyang, et al.
Published: (2021-04-01)

Clinical results of everolimus-eluting stents and sirolimus-eluting stents in patients undergoing percutaneous coronary intervention
by: Iraj Jafaripour, et al.
Published: (2023-05-01)

Ten-year clinical outcomes of everolimus- and biolimus-eluting coronary stents vs. everolimus-eluting bioresorbable vascular scaffolds—insights from the EVERBIO-2 trial
by: Samir Bengueddache, et al.
Published: (2024-09-01)

The Twelve-Month Outcome of Biolimus Eluting Stent with Biodegradable Polymer Compared With an Everolimus Eluting Stent with Durable Polymer
by: Ahmad Separham, et al.
Published: (2011-11-01)

Early and long-term outcomes of bioresorbable vascular scaffolds in the treatment of patients with coronary artery disease in real-world clinical practice – insights from the ZABRZE-BVS registry
by: Jacek Piegza, et al.
Published: (2018-12-01)

One-Year Outcome of Everolimus-Eluting Stents versus Biolimus-Eluting Stents in Patients Undergoing Percutaneous Coronary Intervention
by: Mohammad Alidoosti, et al.
Published: (2016-10-01)

Comparison of diagnostic accuracy of immediate angiography derived residual quantitative flow ratio after bioresorbable scaffold and drug eluting stent implantation
by: Zhengwei Li, et al.
Published: (2022-02-01)

Long-term comparison of everolimus- vs. novolimus-eluting bioresorbable vascular scaffolds in real world patients
by: Beytullah Cakal, et al.
Published: (2020-12-01)

Long-term follow-up of therapeutic efficacy of everolimus-eluting bioresorbable vascular scaffold in comparison to everolimus-eluting stent in treatment of chronic total occlusion guided by intracoronary imaging
by: Mohammad Abdallah Eltahlawi, et al.
Published: (2020-10-01)

Long-term efficacy, safety and biocompatibility of a novel sirolimus eluting iron bioresorbable scaffold in a porcine model
by: Ya-Nan Gao, et al.
Published: (2024-09-01)

Ultrathin Strut Biodegradable Polymer Sirolimus‐Eluting Stent Versus Durable‐Polymer Everolimus‐Eluting Stent for Percutaneous Coronary Revascularization: 2‐Year Results of the BIOSCIENCE Trial
by: Rainer Zbinden, et al.
Published: (2016-03-01)

Everolimus-eluting bioresorbable scaffolds and metallic stents in diabetic patients: a patient-level pooled analysis of the prospective ABSORB DM Benelux Study, TWENTE and DUTCH PEERS
by: T. M. Hommels, et al.
Published: (2020-10-01)

Major adverse cardiovascular events after implantation of absorb bioresorbable scaffold: One-year clinical outcomes
by: Šobot Tanja, et al.
Published: (2021-01-01)

Comparisons of Drug-Eluting Balloon versus Drug-Eluting Stent in the Treatment of Young Patients with Acute Myocardial Infarction
by: Yi-Xing Yang, et al.
Published: (2023-01-01)

Implantation of a bioresorbable vascular scaffold for a left anterior descending artery lesion in a patient with dextrocardia and situs inversus: A rare case with three-year follow-up
by: Vilas Magarkar, et al.
Published: (2017-05-01)

Comparison of clinical outcomes after drug-eluting balloon and drug-eluting stent use for in-stent restenosis related acute myocardial infarction: a retrospective study
by: Chih-Yuan Fang, et al.
Published: (2018-04-01)

Ultra-thin everolimus-eluting stents in atherosclerotic lesions: Three years follow-up with subgroup analysis of ultra-long stents
by: Raghava Sarma Polavarapu, et al.
Published: (2023-07-01)

Coronary Endothelium‐Dependent Vasomotor Function After Drug‐Eluting Stent and Bioresorbable Scaffold Implantation
by: Josep Gomez‐Lara, et al.
Published: (2021-11-01)

Clinical outcomes of ultrathin strut biodegradable polymer-coated everolimus-eluting stent in patients with coronary artery disease
by: Suresh Patted, et al.
Published: (2020-07-01)

Clinical and angiographic outcomes at more than 1 year after treatment of chronic total occlusions with the everolimus-eluting bioresorbable vascular scaffold
by: Aylin Hatice Yamac, et al.
Published: (2016-12-01)

Comparisons of drug-eluting balloon versus drug-eluting stent for the treatment of cancer patients presenting with acute myocardial infarction
by: Yi-Xing Yang, et al.
Published: (2023-09-01)

One-Year Results of the Use of Absorb Bioresorbable Vascular Scaffold in Patients with Different Forms of Coronary Artery Disease as Compared to a Drug-Eluting Stent
by: Nabijon P. Yuldashev, et al.
Published: (2018-03-01)

A Combination of Drug-Eluting Stents and Bioresorbable Vascular Scaffolds in the Treatment of Multivessel Coronary Artery Disease
by: Ahmed Al-Mamary, et al.
Published: (2016-08-01)

Bioresorbable scaffolds vs. drug-eluting stents on short- and mid-term target lesion outcomes in patients after PCI: A systematic review and meta-analysis
by: Yan-di Wan, et al.
Published: (2022-09-01)

Comparative vascular responses three months after paclitaxel and everolimus-eluting stent implantation in streptozotocin-induced diabetic porcine coronary arteries
by: Sheehy Alexander, et al.
Published: (2012-06-01)

Everolimus-eluting bioresorbable scaffolds for treatment of coronary artery disease in patients with diabetes mellitus: the midterm follow-up of the prospective ABSORB DM Benelux study
by: T. M. Hommels, et al.
Published: (2019-03-01)

Interim Results of the Basket of Real-World Randomised Clinical PRISM Trials for M’Sure-S, a Next-Generation Sirolimus-Eluting Stent, Versus Eliminator, an Everolimus-Eluting Stent
by: Marc Silvestri, et al.
Published: (2018-09-01)

Efficacy and safety of durable versus biodegradable polymer drug-eluting stents in patients with acute myocardial infarction complicated by cardiogenic shock
by: Woo Jin Jang, et al.
Published: (2024-03-01)

Bioresorbable vascular stents and drug-eluting stents in treatment of coronary heart disease: a meta-analysis
by: Le Ni, et al.
Published: (2020-01-01)

Short Term Outcome of Drug Eluting Balloon for Percutaneous Coronary Intervention
by: Maida Anwar, et al.
Published: (2023-12-01)

Fabrication of a 3D printed everolimus-eluting stent made of thermoplastic polyurethane and polylactide
by: M. T. Bekov, et al.
Published: (2024-04-01)

Clinical Impact of Dual Antiplatelet Therapy Use in Patients Following Everolimus-eluting Stent Implantation: Insights from the SEEDS Study
by: Yao-Jun Zhang, et al.
Published: (2015-01-01)

Bioresorbable vascular scaffold for coronary in-stent restenosis: A novel concept
by: Surender Deora, et al.
Published: (2014-07-01)

Magnesium bioresorbable scaffold (Magmaris) versus polymer biodegradable ultrathin drug-eluting stent (Ultimaster) in acute coronary syndrome. Mid-term outcomes (2 years)
by: Adrian Włodarczak, et al.
Published: (2024-03-01)

One‐Month Dual Antiplatelet Therapy After Bioresorbable Polymer Everolimus‐Eluting Stents in High Bleeding Risk Patients
by: Carlo A. Pivato, et al.
Published: (2022-03-01)